Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Regencell Bioscience Holdings Ltd RGC

Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.


NDAQ:RGC - Post by User

Post by sungrin1309on Aug 17, 2022 12:18pm
34 Views
Post# 34902360

A sneak peak into RGC background

A sneak peak into RGC backgroundA sneak peak into RGC background

Bioscience is an early-stage bioscience company focused on the research, development, and commercialization of Traditional Chinese Medicine.

Regencell Chairman and CEO, Yat-Gai Au recently purchased more than $5.9 million in RGC shares.

Majority shareholders of Regencell are insider investors.

Regencell is comfortably poised amidst turbulent market conditions, especially for a biotech stock.

The company has a list of successful clinical trials, with more to come in the year.

https://seekingalpha.com/article/4534812-slow-and-steady-wins-the-race-with-regencell-bioscience
<< Previous
Bullboard Posts
Next >>